Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- Check5 days agoChange DetectedThe page no longer shows the Study Protocol and Statistical Analysis Plan and several associated study-document details, removing the linked documents, contributor names, and institution references that help explain the study design and provenance.SummaryDifference16%

- Check12 days agoChange DetectedRecruitment status updated to indicate no participants are being sought; navigation and metadata were updated, including replacing 'Intervention / Treatment' with 'Intervention/Treatment', adding a new 'Revision: v3.6.0' label, and introducing new help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.5%

- Check19 days agoChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5, indicating a minor update to the page documentation. This change does not affect study data, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check33 days agoChange DetectedNo changes were reported for this page in the provided data. The input contains no additions or deletions to describe.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision was updated to v3.5.4 from v3.5.3, indicating an internal update to the page's revision history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor interface or backend release rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.